Advanced Search
Newsfeed
Followed Companies
News Alerts
21,514Followers on Owler
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

Gilead

Read more
Daniel O’Day's photo - Chairman & CEO of Gilead

Chairman & CEO

Daniel O’Day

CEO Approval Rating

53/100

Founded

1987

Headquarters

Status

PublicIndependent CompanyNASDAQGILD

SIC Code

2834 NAICS listing »

Website

Social Links

Annual Revenue
$27.5B
Employees
14,400
Funding
$7.3B
Industry
Pharmaceuticals & Biotechnology
Sector
Pharmaceuticals
Biotechnology

Gilead Competitors and Alternatives

1
3
5
7
9
2
4
6
8
10
See more competitor data

Key Highlights

Sign up for free to see more
Acquisition
Gilead acquired MYR Pharmaceuticals for $1.4B
Dec 10, 2020
investment
Gilead Sciences, Inc. has invested $85M in Kyverna Therapeutics, Inc.
Jan 25, 2022
Fraud
Gilead Secures Legal Victory in Battle Against HIV Drug Fraud
Apr 20, 2022
ESG
Bristol Myers Squibb Foundation Honors Diversity and Health Equity Leader By Naming Diversity in Clinical Trials Training Program After Him; Welcomes Gilead Sciences as Program Supporter
Apr 11, 2022
Layoffs
After layoffs, Gilead to build NJ hub that will house up to 500 employees
Mar 24, 2022
Conference Presentation
Gilead Sciences to Present at Upcoming Investor Conference
Dec 21, 2021

Looking for similar companies to Gilead?

Gilead Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$27.5B

Gilead's revenue is the ranked 13th among it's top 10 competitors. The top 10 competitors average 36B. Over the last four quarters, Gilead's revenue has grown by 6%. Specifically, in Q1 2022's revenue was $6.6B; in Q4 2021, it was $7.2B; in Q3 2021, it was $7.4B; in Q2 2021, Gilead's revenue was $6.2B.

Gilead News

Gilead Press Releases

Gilead Videos

Gilead Headquarters

333 Lakeside Drive

Foster City, California94404

1-650-574-3000

Driving Directions »

Gilead Summary

ABOUT

Overview

Gilead develops and commercializes therapeutics for the treatment of liver, cancer, inflammatory, respiratory and cardiovascular diseases. Gilead was founded in 1987. Gilead's headquarters is located in Foster City, California, USA 94404. Gilead's Ch...

CEO

Gilead's Chairman & CEO, Daniel O’Day, currently has an approval rating of 53%. Gilead's primary competitors are AbbVie, Merck & BMS.

Website

gilead.com

Competitors

View 20 Gilead competitors here.

Acquisitions

View 10 companies acquired by Gilead here.

Funding

View Gilead funding details.

Investments

View 16 Gilead investments here.

Frequently Asked Questions about Gilead

  1. When was Gilead founded?

    Gilead was founded in 1987

  2. Who is Gilead's CEO?

    Gilead's CEO is Daniel O’Day

  3. How much revenue does Gilead generate?

    Gilead generates $27.5B in revenue

  4. How much funding does Gilead have?

    Gilead has historically raised $7.3B in funding

  5. Where is Gilead's headquarters?

    Gilead's headquarters is in Foster City California, USA

  1. How many employees does Gilead have?

    Gilead has 14,400 employees

  2. What sector does Gilead operate in?

    Gilead is in Pharmaceuticals, Biotechnology

  3. Who are Gilead's competitors?

    Gilead's top competitors are AbbVie, Merck, BMS

  4. Who has Gilead invested in?

    Gilead's has invested in companies such as Kyverna, Gritstone Bio, Pardes Biosciences
Stay up-to-date with the latest news on Gilead

Trending Companies